The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer.

Within tumors there appears to be an intricate balance between hyaluronan (HA) synthesis and degradation where the invading edges display increased HA metabolism. The metabolism of HA has not been characterized in breast cancer cell lines; therefore, this study quantitatively identifies and characterizes the enzymes responsible for the synthesis and degradation of HA while correlating gene expression to cancer cell invasiveness and HA receptor status. In ten well-established breast cancer cell lines, the expression of the genes for each hyaluronan synthase (HAS) and hyaluronidase (Hyal) isoform was quantitated using real-time and reverse transcriptase polymerase chain reaction (PCR). The synthesis and degradation rates of hyaluronan were determined by ELISA, while quantitation of HA receptors, CD44 and RHAMM was performed by comparative Western blotting. The molecular weight of HA synthesized by each HAS isoform and the degradation products of each hyaluronidase were characterized by size exclusion chromatography. It was demonstrated that highly invasive cell lines preferentially expressed the HAS2 and Hyal-2 isoforms, while less invasive cells expressed HAS3 and Hyal-3. There was a correlation between elevated levels of HA synthesis, CD44 expression and cancer cell migration thereby highlighting the pivotal role that HA metabolism plays in the aggressive breast cancer phenotype.

[1]  R. Timpl,et al.  Molecular and Cellular Aspects of Basement Membranes , 1993 .

[2]  M. Culty,et al.  Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: Correlation with invasive potential , 1994, Journal of cellular physiology.

[3]  M. Tammi,et al.  Hyaluronan Enters Keratinocytes by a Novel Endocytic Route for Catabolism* , 2001, The Journal of Biological Chemistry.

[4]  K. Kimata,et al.  Molecular cloning of human hyaluronan synthase. , 1996, Biochemical and biophysical research communications.

[5]  L. Bourguignon.  CD44-Mediated Oncogenic Signaling and Cytoskeleton Activation During Mammary Tumor Progression , 2001, Journal of Mammary Gland Biology and Neoplasia.

[6]  P. Heldin,et al.  Expression of recombinant hyaluronan synthase (HAS) isoforms in CHO cells reduces cell migration and cell surface CD44. , 1999, Experimental cell research.

[7]  A. Csoka,et al.  The six hyaluronidase-like genes in the human and mouse genomes. , 2001, Matrix biology : journal of the International Society for Matrix Biology.

[8]  V. Kosma,et al.  Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. , 2000, The American journal of pathology.

[9]  S. Kumar,et al.  The role of hyaluronan in tumour neovascularization (review) , 1995, International journal of cancer.

[10]  A. Schor,et al.  Mechanism of action of the migration stimulating factor produced by fetal and cancer patient fibroblasts: Effect on hyaluronic acid synthesis , 1989, In Vitro Cellular & Developmental Biology.

[11]  P. Prehm,et al.  Isolation of streptococcal hyaluronate synthase. , 1986, The Biochemical journal.

[12]  R. Kosaki,et al.  Overproduction of hyaluronan by expression of the hyaluronan synthase Has2 enhances anchorage-independent growth and tumorigenicity. , 1999, Cancer research.

[13]  J. Fraser,et al.  On the pericellular zone of some mammalian cells in vitro. , 1968, Experimental cell research.

[14]  R. Stern,et al.  Inhibitors of the hyaluronidases. , 2002, Matrix biology : journal of the International Society for Matrix Biology.

[15]  M. Rahmanian,et al.  Testicular hyaluronidase induces tubular structures of endothelial cells grown in three‐dimensional colagen gel through a CD44‐mediated mechanism , 2002, International journal of cancer.

[16]  T. Oegema,et al.  Manipulation of Hyaluronan Synthase Expression in Prostate Adenocarcinoma Cells Alters Pericellular Matrix Retention and Adhesion to Bone Marrow Endothelial Cells* , 2002, The Journal of Biological Chemistry.

[17]  A. Madan,et al.  Expression of PH-20 in normal and neoplastic breast tissue. , 2002, The Journal of surgical research.

[18]  P. Lenas,et al.  Three Isoforms of Mammalian Hyaluronan Synthases Have Distinct Enzymatic Properties* , 1999, The Journal of Biological Chemistry.

[19]  P. Watson,et al.  The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[20]  V. Kosma,et al.  High stromal hyaluronan level is associated with poor differentiation and metastasis in prostate cancer. , 2001, European journal of cancer.

[21]  J. Minna,et al.  Stromal and Epithelial Expression of Tumor Markers Hyaluronic Acid and HYAL1 Hyaluronidase in Prostate Cancer* , 2001, The Journal of Biological Chemistry.

[22]  M. Rahmanian,et al.  Expression of hyaluronan synthase 2 or hyaluronidase 1 differentially affect the growth rate of transplantable colon carcinoma cell tumors , 2002, International journal of cancer.

[23]  Shant Kumar,et al.  Angiogenic oligosaccharides of hyaluronan enhance the production of collagens by endothelial cells. , 1993, Journal of cell science.

[24]  R. Stern.  Devising a pathway for hyaluronan catabolism: are we there yet? , 2003, Glycobiology.

[25]  H. Kleinman,et al.  The basement membrane matrix in malignancy , 2003, The Journal of pathology.

[26]  S. Suzuki,et al.  Increased synthesis of hyaluronic acid by mouse mammary carcinoma cell variants with high metastatic potential. , 1983, Cancer research.

[27]  R. Stern,et al.  Hyaluronidases in tissue invasion. , 1997, Invasion & metastasis.

[28]  G. Box,et al.  Hyaluronidase gene profiling and role of HYAL‐1 overexpression in an orthotopic model of prostate cancer , 2002, International journal of cancer.

[29]  Takahiro Sawai,et al.  Abnormal accumulation of hyaluronan matrix diminishes contact inhibition of cell growth and promotes cell migration , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Stern,et al.  Inhibition of hyaluronan degradation by dextran sulphate facilitates characterisation of hyaluronan synthesis: An in vitro and in vivo study , 2003, Glycoconjugate Journal.

[31]  J. Folkman.  Role of angiogenesis in tumor growth and metastasis. , 2002, Seminars in oncology.

[32]  S. Kumar,et al.  Application of angiogenic oligosaccharides of hyaluronan increases blood vessel numbers in rat skin. , 1994, The Journal of investigative dermatology.

[33]  I. Kovalszky,et al.  Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer. , 2002, Seminars in cancer biology.

[34]  F. Duh,et al.  Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[35]  F. Gao,et al.  Hyaluronan synthase 3 overexpression promotes the growth of TSU prostate cancer cells. , 2001, Cancer research.

[36]  P. Prehm.  Release of hyaluronate from eukaryotic cells. , 1990, The Biochemical journal.

[37]  Ronit Vogt Sionov,et al.  CD44: structure, function, and association with the malignant process. , 1997, Advances in cancer research.

[38]  E. Turley,et al.  Hyaluronan and cell locomotion , 1992, Cancer and Metastasis Reviews.

[39]  V. Kosma,et al.  Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. , 1998, Cancer research.

[40]  V. Kosma,et al.  Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate , 1999, British Journal of Cancer.

[41]  B. Toole.  Hyaluronan promotes the malignant phenotype. , 2002, Glycobiology.

[42]  U. Schumacher,et al.  Expression of hyaluronate and hyaluronate synthase in human primary tumours and their metastases in scid mice. , 2002, Cancer letters.

[43]  P. Prehm,et al.  Increased hyaluronate synthesis is required for fibroblast detachment and mitosis. , 1986, The Biochemical journal.

[44]  K. Kimata,et al.  Relationship between hyaluronan production and metastatic potential of mouse mammary carcinoma cells. , 1999, Cancer research.

[45]  M. Tammi,et al.  Hyaluronan-Cell Interactions in Cancer and Vascular Disease* , 2002, The Journal of Biological Chemistry.

[46]  J. Willson,et al.  Expression of hyaluronidase by tumor cells induces angiogenesis in vivo. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[47]  S. Scherer,et al.  The hyaluronidase gene HYAL1 maps to chromosome 3p21.2-p21.3 in human and 9F1-F2 in mouse, a conserved candidate tumor suppressor locus. , 1998, Genomics.

[48]  R. Kannagi,et al.  Selective Expression and Functional Characteristics of Three Mammalian Hyaluronan Synthases in Oncogenic Malignant Transformation* , 2003, Journal of Biological Chemistry.

[49]  G. Kreil.  Hyaluronidases — a group of neglected enzymes , 1995, Protein science : a publication of the Protein Society.

[50]  S. Stylli,et al.  Hyaluronidase-2 overexpression accelerates intracerebral but not subcutaneous tumor formation of murine astrocytoma cells. , 1999, Cancer research.